| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1085704866 |
| P356 | DOI | 10.1186/S12890-017-0430-6 |
| P932 | PMC publication ID | 5450144 |
| P698 | PubMed publication ID | 28558662 |
| P50 | author | Babafemi Taiwo | Q69963952 |
| Robert L. Murphy | Q39793026 | ||
| P2093 | author name string | Mamoudou Maiga | |
| John Idoko | |||
| Chad Achenbach | |||
| Oche Agbaji | |||
| Agatha Ani | |||
| Patrick Akande | |||
| Christiana Ukoli | |||
| Maxwell Oluwole Akanbi | |||
| Yetunde Isa | |||
| P2860 | cites work | Diagnostic defaulters: an overlooked aspect in the Indian Revised National Tuberculosis Control Program | Q43773625 |
| Mycobacterium tuberculosis and non-tuberculous mycobacteria isolates from HIV-infected patients in Guangxi, China | Q61624853 | ||
| Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults | Q24201466 | ||
| Diagnosis and Treatment of Nontuberculous Mycobacterial Lung Disease: Clinicians' Perspectives | Q26749480 | ||
| Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective study | Q28479309 | ||
| The growing burden of tuberculosis: global trends and interactions with the HIV epidemic | Q29616520 | ||
| Rapid molecular detection of tuberculosis and rifampin resistance | Q29617127 | ||
| Impact of Xpert MTB/RIF testing on tuberculosis management and outcomes in hospitalized patients in Uganda | Q31106576 | ||
| Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology | Q33614228 | ||
| Diagnostic delays and clinical decision making with centralized Xpert MTB/RIF testing in Durban, South Africa | Q34340867 | ||
| The hidden costs of installing Xpert machines in a tuberculosis high-burden country: experiences from Nigeria. | Q34644840 | ||
| Prevalence of non-tuberculous mycobacterial infections among tuberculosis suspects in Nigeria | Q34721056 | ||
| Clinical predictors and accuracy of empiric tuberculosis treatment among sputum smear-negative HIV-infected adult TB suspects in Uganda | Q34989654 | ||
| Tuberculosis treatment delays and associated factors within the Zimbabwe national tuberculosis programme | Q35041185 | ||
| Impact of Xpert MTB/RIF on Antiretroviral Therapy-Associated Tuberculosis and Mortality: A Pragmatic Randomized Controlled Trial | Q35071965 | ||
| Intensive tuberculosis screening for HIV-infected patients starting antiretroviral therapy in Durban, South Africa | Q35486137 | ||
| Evaluating the Diagnostic Accuracy of Xpert MTB/RIF Assay in Pulmonary Tuberculosis | Q35818752 | ||
| Testing Pooled Sputum with Xpert MTB/RIF for Diagnosis of Pulmonary Tuberculosis To Increase Affordability in Low-Income Countries | Q35868619 | ||
| Genetic determinants of drug-resistant tuberculosis among HIV-infected patients in Nigeria | Q36172190 | ||
| Diagnostic Accuracy of Xpert Test in Tuberculosis Detection: A Systematic Review and Meta-analysis | Q36671821 | ||
| An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases | Q36727850 | ||
| Implementation of Xpert MTB/RIF in Uganda: Missed Opportunities to Improve Diagnosis of Tuberculosis | Q36899978 | ||
| Evaluation of the Xpert® MTB/RIF assay and microscopy for the diagnosis of Mycobacterium tuberculosis in Namibia | Q37586825 | ||
| Xpert(®) MTB/RIF for point-of-care diagnosis of TB in high-HIV burden, resource-limited countries: hype or hope? | Q37801942 | ||
| Autopsy causes of death in HIV-positive individuals in sub-Saharan Africa and correlation with clinical diagnoses. | Q37823213 | ||
| High initial default in patients with smear-positive pulmonary tuberculosis at a regional hospital in Accra, Ghana | Q38015507 | ||
| Do high rates of empirical treatment undermine the potential effect of new diagnostic tests for tuberculosis in high-burden settings? | Q38179563 | ||
| Tuberculosis among nomads in Adamawa, Nigeria: outcomes from two years of active case finding | Q39191163 | ||
| Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial | Q39520488 | ||
| Factors affecting time delay to treatment in a tuberculosis control programme in a sub-Saharan African country: the experience of The Gambia. | Q39565437 | ||
| Are three sputum acid-fast bacillus smears necessary for discontinuing tuberculosis isolation? | Q39664529 | ||
| P433 | issue | 1 | |
| P921 | main subject | Nigeria | Q1033 |
| P304 | page(s) | 87 | |
| P577 | publication date | 2017-05-30 | |
| P1433 | published in | BMC Pulmonary Medicine | Q15755469 |
| P1476 | title | Evaluation of gene xpert for routine diagnosis of HIV-associated tuberculosis in Nigeria: A prospective cohort study | |
| P478 | volume | 17 |
Search more.